Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Abbott Laboratories

NYSE

Market Cap.

180.83B

Avg. Volume

5.75M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Abbott Laboratories!

Still processing it, give me a bit more time...

Abbott Laboratories News

Abbott Laboratories Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Devices
abbott.com

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories Earnings & Revenue

Abbott Laboratories Financials

Table Compare

Compare ABT metrics with:

   

Earnings & Growth

ABT

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ABT

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ABT

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ABT

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Abbott Laboratories Income

Abbott Laboratories Balance Sheet

Abbott Laboratories Cash Flow

Abbott Laboratories Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Abbott Laboratories Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.1200

Payment DateDividendFrequency
2024-05-150.55Quarterly
2024-02-150.55Quarterly
2023-11-150.51Quarterly
2023-08-150.51Quarterly
2023-05-150.51Quarterly

Historical Market Cap

Shares Outstanding

Abbott Laboratories Executives

NameRole
Mr. Robert B. FordChairman of the Board, President & Chief Executive Officer
Mr. Robert E. Funck Jr.Executive Vice President of Finance
Mr. Hubert L. AllenExecutive Vice President, General Counsel & Secretary
Mr. Daniel Gesua Sive SalvadoriExecutive Vice President and Group President of Established Pharmaceuticals & Nutritional Products
Ms. Lisa D. EarnhardtExecutive Vice President & Group President of Medical Devices
NameRoleGenderDate of BirthPay
Mr. Robert B. FordChairman of the Board, President & Chief Executive OfficerMale19744.73M
Mr. Robert E. Funck Jr.Executive Vice President of FinanceMale19612.18M
Mr. Hubert L. AllenExecutive Vice President, General Counsel & SecretaryMale19662M
Mr. Daniel Gesua Sive SalvadoriExecutive Vice President and Group President of Established Pharmaceuticals & Nutritional ProductsMale19791.76M
Ms. Lisa D. EarnhardtExecutive Vice President & Group President of Medical DevicesFemale19701.73M

Abbott Laboratories Insider Trades

Date10 May
NameFunck, Jr. Robert E.
RoleEXECUTIVE VICE PRESIDENT
TransactionAcquired
TypeM-Exempt
Shares10097
Date10 May
NameFunck, Jr. Robert E.
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeS-Sale
Shares10097
Date10 May
NameFunck, Jr. Robert E.
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeM-Exempt
Shares10097
Date7 May
NameEarnhardt Lisa D
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeS-Sale
Shares22852
Date26 Apr
NameStratton John G
RoleDirector
TransactionAcquired
TypeA-Award
Shares1866
DateNameRoleTransactionTypeShares
10 MayFunck, Jr. Robert E.EXECUTIVE VICE PRESIDENTAcquiredM-Exempt10097
10 MayFunck, Jr. Robert E.EXECUTIVE VICE PRESIDENTDisposedS-Sale10097
10 MayFunck, Jr. Robert E.EXECUTIVE VICE PRESIDENTDisposedM-Exempt10097
7 MayEarnhardt Lisa DEXECUTIVE VICE PRESIDENTDisposedS-Sale22852
26 AprStratton John GDirectorAcquiredA-Award1866

Discover More

Streamlined Academy

Abbott Laboratories

NYSE

Market Cap.

180.83B

Avg. Volume

5.75M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Abbott Laboratories News

Abbott Laboratories Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Abbott Laboratories Earnings & Revenue

Abbott Laboratories Income

Abbott Laboratories Balance Sheet

Abbott Laboratories Cash Flow

Abbott Laboratories Financials Over Time

Abbott Laboratories Executives

NameRole
Mr. Robert B. FordChairman of the Board, President & Chief Executive Officer
Mr. Robert E. Funck Jr.Executive Vice President of Finance
Mr. Hubert L. AllenExecutive Vice President, General Counsel & Secretary
Mr. Daniel Gesua Sive SalvadoriExecutive Vice President and Group President of Established Pharmaceuticals & Nutritional Products
Ms. Lisa D. EarnhardtExecutive Vice President & Group President of Medical Devices
NameRoleGenderDate of BirthPay
Mr. Robert B. FordChairman of the Board, President & Chief Executive OfficerMale19744.73M
Mr. Robert E. Funck Jr.Executive Vice President of FinanceMale19612.18M
Mr. Hubert L. AllenExecutive Vice President, General Counsel & SecretaryMale19662M
Mr. Daniel Gesua Sive SalvadoriExecutive Vice President and Group President of Established Pharmaceuticals & Nutritional ProductsMale19791.76M
Ms. Lisa D. EarnhardtExecutive Vice President & Group President of Medical DevicesFemale19701.73M

Abbott Laboratories Insider Trades

Date10 May
NameFunck, Jr. Robert E.
RoleEXECUTIVE VICE PRESIDENT
TransactionAcquired
TypeM-Exempt
Shares10097
Date10 May
NameFunck, Jr. Robert E.
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeS-Sale
Shares10097
Date10 May
NameFunck, Jr. Robert E.
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeM-Exempt
Shares10097
Date7 May
NameEarnhardt Lisa D
RoleEXECUTIVE VICE PRESIDENT
TransactionDisposed
TypeS-Sale
Shares22852
Date26 Apr
NameStratton John G
RoleDirector
TransactionAcquired
TypeA-Award
Shares1866
DateNameRoleTransactionTypeShares
10 MayFunck, Jr. Robert E.EXECUTIVE VICE PRESIDENTAcquiredM-Exempt10097
10 MayFunck, Jr. Robert E.EXECUTIVE VICE PRESIDENTDisposedS-Sale10097
10 MayFunck, Jr. Robert E.EXECUTIVE VICE PRESIDENTDisposedM-Exempt10097
7 MayEarnhardt Lisa DEXECUTIVE VICE PRESIDENTDisposedS-Sale22852
26 AprStratton John GDirectorAcquiredA-Award1866

Streamlined Academy

Website screenshot
HealthcareMedical - Devices
abbott.com

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Abbott Laboratories!

Still processing it, give me a bit more time...

Abbott Laboratories Financials

Table Compare

Compare ABT metrics with:

   

Earnings & Growth

ABT

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ABT

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ABT

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ABT

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Abbott Laboratories Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.1200

Payment DateDividendFrequency
2024-05-150.55Quarterly
2024-02-150.55Quarterly
2023-11-150.51Quarterly
2023-08-150.51Quarterly
2023-05-150.51Quarterly

Abbott Laboratories Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More